LogoLogoMSF Science Portal
  • My saved items
logo

© Médecins Sans Frontières

MSF Science Portal
About MSF Science Portal
About MSF
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use

v2.1.4829.produseast1

9 result(s)
Filter and sort
9 result(s)
Journal Article > LetterSubscription Only

Equitable access needed in clinical research

Science. 28 March 2025; Volume 387 (Issue 6741); 1361-1362.; DOI:10.1126/science.adv2394
Dang G, Perrin C, Furin J
Science. 28 March 2025; Volume 387 (Issue 6741); 1361-1362.; DOI:10.1126/science.adv2394
Journal Article > CommentaryFull Text

An oral antiviral for Ebola disease

Science. 15 March 2024; Volume 383 (Issue 6688); 1181-1182.; DOI:10.1126/science.ado6257
Sprecher A, Van Herp M
Science. 15 March 2024; Volume 383 (Issue 6688); 1181-1182.; DOI:10.1126/science.ado6257
For those exposed to filovirus, such as Sudan virus and Ebola virus, a new study offers hope.
Journal Article > CommentaryAbstract Only

Strengthening the evidence base for health programming in humanitarian crises

Science. 12 September 2014; Volume 345 (Issue 6202); 1290-1292.; DOI:10.1126/science.1254164
Ager A, Burnham G, Checchi F, Gayer M, Grais RF,  et al.
Science. 12 September 2014; Volume 345 (Issue 6202); 1290-1292.; DOI:10.1126/science.1254164
Given the growing scale and complexity of responses to humanitarian crises, it is important to develop a stronger evidence base for health interventions in such contexts. Humanitarian crises present unique challenges to rigorous and effective research, but there are substantial opportunities for scientific advance. Studies need to focus where the translation of evidence from noncrisis scenarios is not viable and on ethical ways of determining what happens in the absence of an intervention. Robust methodologies suited to crisis settings have to be developed and used to assess interventions with potential for delivery at scale. Strengthening research capacity in the low- to middle-income countries that are vulnerable to crises is also crucial.More
Journal Article > Short ReportFull Text

Explaining seasonal fluctuations of measles in Niger using nighttime lights imagery

Science. 9 December 2011; Volume 334 (Issue 6061); DOI:10.1126/science.1210554
Bharti N, Tatem AJ, Ferrari MJ, Grais RF, Djibo A,  et al.
Science. 9 December 2011; Volume 334 (Issue 6061); DOI:10.1126/science.1210554
Measles epidemics in West Africa cause a significant proportion of vaccine-preventable childhood mortality. Epidemics are strongly seasonal, but the drivers of these fluctuations are poorly understood, which limits the predictability of outbreaks and the dynamic response to immunization. We show that measles seasonality can be explained by spatiotemporal changes in population density, which we measure by quantifying anthropogenic light from satellite imagery. We find that measles transmission and population density are highly correlated for three cities in Niger. With dynamic epidemic models, we demonstrate that measures of population density are essential for predicting epidemic progression at the city level and improving intervention strategies. In addition to epidemiological applications, the ability to measure fine-scale changes in population density has implications for public health, crisis management, and economic development.More
Journal Article > CommentaryAbstract

Universal access in the fight against HIV/AIDS

Science. 9 July 2010; Volume 329 (Issue 5988); DOI:10.1126/science.1193294
Girard F, Ford NP, Montaner JSG, Cahn P, Katabira E
Science. 9 July 2010; Volume 329 (Issue 5988); DOI:10.1126/science.1193294
Journal Article > CommentaryFull Text

Public Health. Responding to market failures in tuberculosis control

Science. 10 August 2001; Volume 293 (Issue 5532); 1049-1051.; DOI:10.1126/science.1061861
Gupta RS, Kim JH, Espinal MA, Caudron JM, Pecoul B,  et al.
Science. 10 August 2001; Volume 293 (Issue 5532); 1049-1051.; DOI:10.1126/science.1061861
Journal Article > ResearchAbstract Only

Genomic history of the seventh pandemic of cholera in Africa

Science. 10 November 2017; Volume 358 (Issue 6364); 785-789.; DOI:10.1126/science.aad5901
Weill FX, Domman D, Njamkepo E, Tarr C, Rauzier J,  et al.
Science. 10 November 2017; Volume 358 (Issue 6364); 785-789.; DOI:10.1126/science.aad5901
The seventh cholera pandemic has heavily affected Africa, although the origin and continental spread of the disease remain undefined. We used genomic data from 1070 Vibrio cholerae O1 isolates, across 45 African countries and over a 49-year period, to show that past epidemics were attributable to a single expanded lineage. This lineage was introduced at least 11 times since 1970, into two main regions, West Africa and East/Southern Africa, causing epidemics that lasted up to 28 years. The last five introductions into Africa, all from Asia, involved multidrug-resistant sublineages that replaced antibiotic-susceptible sublineages after 2000. This phylogenetic framework describes the periodicity of lineage introduction and the stable routes of cholera spread, which should inform the rational design of control measures for cholera in Africa.More
Journal Article > CommentaryFull Text

Public Health. The cholera crisis in Africa

Science. 14 May 2009; Volume 324 (Issue 5929); DOI:10.1126/science.1173890
Bhattacharya S, Black RE, Bourgeois L, Clemens JD, Cravioto A,  et al.
Science. 14 May 2009; Volume 324 (Issue 5929); DOI:10.1126/science.1173890
Journal Article > CommentaryFull Text

Getting HIV treatment to the most people

Science. 20 July 2012; Volume 337 (Issue 6092); 298-300.; DOI:10.1126/science.1225702
Lynch S, Ford NP, van Cutsem G, Bygrave H, Janssens B,  et al.
Science. 20 July 2012; Volume 337 (Issue 6092); 298-300.; DOI:10.1126/science.1225702
The new understanding that antiretroviral therapy (ART) can significantly reduce HIV transmission has stimulated scientific and political leaders to claim that ending the AIDS epidemic is now a realistic goal. At the same time and despite last year's major international political commitments to put 15 million people on treatment by 2015, large funding gaps threaten the gains already made and limit the potential to capitalize on the latest scientific progress. Underresourced clinics are managing ever-increasing numbers of people on treatment, even though there is attrition all along the care continuum, from testing to treatment initiation and long-term retention in care.More